文献速递淋巴瘤白血病浆细胞疾病

犬血液系统恶性肿瘤入门介绍

Bite-size introduction to canine hematologic malignancies.
PubMed 文献 · Blood Adv · 2022-01-01

犬血液系统恶性肿瘤常见,包括淋巴瘤、淋系和髓系白血病及肥大细胞、浆细胞和组织细胞肿瘤,表现与结局异质。本文介绍其致病驱动因素、临床表现和标准治疗,并指出比较肿瘤学价值使参与犬癌症研究的临床医生和科学家预计增多。

要点

  • 犬最常见血液系统肿瘤包括淋巴瘤、淋系和髓系白血病、肥大细胞肿瘤、浆细胞肿瘤和组织细胞肿瘤。
  • 不同类别和亚型的犬血液系统恶性肿瘤表现异质,结局可变。
  • 治疗选择从积极监测到以治愈为目的的手术、化疗和放疗。

核心结论

  • 本文旨在提供犬血液系统恶性肿瘤的入门性概述。
  • 犬血液系统肿瘤的致病驱动因素与临床表现被介绍,并概述各病的标准治疗。
  • 随着比较肿瘤学获得认可,参与犬癌症研究的临床医生和科学家数量预计增加。

研究设计与样本

  • 综述,旨在提供犬血液系统恶性肿瘤的入门性概述。

主要发现

  • 犬常被诊断血液系统恶性肿瘤,并出现与特定疾病类型相关的系列临床症状。
  • 犬最常见血液系统肿瘤包括淋巴瘤、淋系和髓系白血病,以及肥大细胞、浆细胞和组织细胞肿瘤。
  • 不同类别和亚型的犬血液系统恶性肿瘤表现异质,这些肿瘤的结局也可变。
  • 许多此类疾病的潜在病理与人类患者相应诊断的病理高度相似。

临床怎么用

  • 考虑到表现异质和结局可变,适当的治疗选择范围从积极监测到利用手术、化疗和放疗方式的以治愈为目的的方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hematologic malignancies are frequently diagnosed in dogs and result in a spectrum of clinical signs associated with specific disease types. The most frequently encountered hematologic tumors in dogs include lymphoma, lymphoid and myeloid leukemias, and mast cell, plasma cell, and histiocytic neoplasias. Coupled with the heterogeneous presentations of the different categories and subtypes of canine hematologic malignancies, outcomes for these tumors are also variable. Considering this, appropriate treatment options range from active surveillance to curative intent approaches harnessing surgical, chemotherapeutic, and radiation-based modalities. The underlying pathology of many of these diseases bears remarkable resemblance to that of the corresponding diagnosis made in human patients. We introduce some of the pathogenic drivers of canine hematologic cancers alongside their clinical presentations. An overview of standard-of-care therapies for each of these diseases is also provided. As comparative oncology gains recognition as a valuable setting in which to investigate the pathogenesis of neoplasia and provide powerful, clinically relevant, immunocompetent models for the evaluation of novel therapies, the number of clinicians and scientists participating in cancer research involving dogs is expected to increase. This review aims at providing an introductory overview of canine hematologic malignancies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Atherton MJ, Mason NJ. Bite-size introduction to canine hematologic malignancies. Blood Adv. 2022. PMID: 35316831. doi:10.1182/bloodadvances.2021005045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。